Kratom attracts investor attention after regulatory win
Looks like the recent decision by the World Health Organization to decline a “critical revue” of Kratom is spurring pharmaceutical interest in our favorite plant.
Kratom attracts investor attention after regulatory win
Looks like the recent decision by the World Health Organization to decline a “critical revue” of Kratom is spurring pharmaceutical interest in our favorite plant.
@pete2000 Thanks for the link. 👍 Big pharma always takes plants apart to the molecular level, and twist it into something stronger/evil. (poppy sap, cannabis flower, coca leaves, and now kratom and mushrooms!)
follow the money, its leads to patents on plants and to big phama.